Press Release Distribution & PR Platform - ACCESS Newswire
6 hours ago • Google News
Aytu BioScience Inc (AYTU)
US$ 1.64-9.65%
Price Chart
Key Statistics
Market Cap
$ 6.48M
P/E Ratio
0.00
Revenue (TTM)
$ 77.23M
Volume
68.08K
52W High
$ 3.45
52W Low
$ 0.95
Dividend Yield
0.00%
Beta
0.07
Technicals
50-Day MA
1.1972
200-Day MA
1.8672
52 Week High
3.4475
52 Week Low
0.95
About AYTU
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.
Employees
102
Headquarters
Denver, CO
CEO
Mr. Joshua R. Disbrow
Latest News
Aytu BioPharma CEO Reveals Growth Strategy at Exclusive Vegas Investor Showcase - Stock Titan
4 days ago • Google News
Aytu BioPharma at Planet MicroCap: Strategic Realignment and Growth - Investing.com
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg